HF10 therapy delivers stimulation at 10,000 Hz — significantly higher than traditional SCS which operates at 40-60 Hz. This advanced waveform provides pain relief without the tingling sensation (paresthesia) associated with traditional stimulation.
HF10 is the only SCS therapy FDA-approved for both back and leg pain. Clinical studies show sustained pain relief at 5+ years with superior outcomes for chronic back pain compared to traditional SCS.
The implant process is identical to traditional SCS. The key difference is the programming: patients feel no tingling or buzzing sensation, only pain relief. Relief develops gradually over the first 1-2 weeks of use.
High-frequency stimulation at 10 kHz is believed to work through mechanisms distinct from traditional low-frequency SCS. Rather than replacing the pain sensation with paresthesia (which can be uncomfortable for some patients), HF10 appears to directly suppress pain signaling in the spinal cord through multiple mechanisms including wide dynamic range neuron inhibition and modulation of descending pain inhibitory pathways.
The leads are placed in the midline of the posterior epidural space, typically with the tip at the T8-T9 level for back and leg pain coverage.
The trial and implant procedures are identical to traditional SCS. During the trial, patients are blinded to whether they receive HF10 or conventional stimulation to ensure an objective assessment. Patients keep a pain diary to document outcomes.
Once activated, patients do not feel the stimulation — there is no tingling or buzzing sensation. Pain relief typically develops gradually over the first 1-2 weeks of use.
Recovery is identical to traditional SCS implant with 6-8 weeks of activity restrictions. The generator for HF10 systems is typically larger and requires a rechargeable battery that is charged weekly for 30-60 minutes.
Patients appreciate the absence of position-related changes in stimulation intensity, a common complaint with traditional low-frequency SCS.
HF10 is appropriate for patients with chronic back and leg pain who have failed conservative management. The absence of paresthesia makes it particularly attractive for patients who find traditional SCS uncomfortable or who experience unpleasant stimulation with positional changes.
Reducing Pain. Improving Function. Enhancing Quality of Life.
We specialize in advanced pain management solutions, offering minimally invasive treatments to help patients live pain-free and improve their quality of life.